ABSI
Price
$2.78
Change
+$0.05 (+1.83%)
Updated
Jun 3 closing price
Capitalization
354.62M
76 days until earnings call
CRSP
Price
$38.04
Change
+$1.09 (+2.95%)
Updated
Jun 3 closing price
Capitalization
3.29B
68 days until earnings call
Interact to see
Advertisement

ABSI vs CRSP

Header iconABSI vs CRSP Comparison
Open Charts ABSI vs CRSPBanner chart's image
Absci
Price$2.78
Change+$0.05 (+1.83%)
Volume$1.56M
Capitalization354.62M
CRISPR Therapeutics AG
Price$38.04
Change+$1.09 (+2.95%)
Volume$1.84M
Capitalization3.29B
ABSI vs CRSP Comparison Chart
Loading...
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABSI vs. CRSP commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABSI is a Hold and CRSP is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (ABSI: $2.78 vs. CRSP: $38.04)
Brand notoriety: ABSI and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABSI: 55% vs. CRSP: 83%
Market capitalization -- ABSI: $354.62M vs. CRSP: $3.29B
ABSI [@Biotechnology] is valued at $354.62M. CRSP’s [@Biotechnology] market capitalization is $3.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $321.16B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABSI’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • ABSI’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, ABSI is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABSI’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 6 bullish TA indicator(s).

  • ABSI’s TA Score: 4 bullish, 5 bearish.
  • CRSP’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than ABSI.

Price Growth

ABSI (@Biotechnology) experienced а +2.21% price change this week, while CRSP (@Biotechnology) price change was +1.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.76%. For the same industry, the average monthly price growth was +2.77%, and the average quarterly price growth was +0.74%.

Reported Earning Dates

ABSI is expected to report earnings on Aug 19, 2025.

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+5.76% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.29B) has a higher market cap than ABSI($355M). ABSI YTD gains are higher at: 6.107 vs. CRSP (-3.354). ABSI has higher annual earnings (EBITDA): -83.27M vs. CRSP (-455.24M). CRSP has more cash in the bank: 1.86B vs. ABSI (127M). ABSI has less debt than CRSP: ABSI (12M) vs CRSP (219M). CRSP has higher revenues than ABSI: CRSP (35M) vs ABSI (4.21M).
ABSICRSPABSI / CRSP
Capitalization355M3.29B11%
EBITDA-83.27M-455.24M18%
Gain YTD6.107-3.354-182%
P/E RatioN/AN/A-
Revenue4.21M35M12%
Total Cash127M1.86B7%
Total Debt12M219M5%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABSICRSP
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
72%
Momentum
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
84%
MACD
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
70%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
76%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 14 days ago
90%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
75%
Aroon
ODDS (%)
Bullish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ABSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FVLAX19.93N/A
N/A
Fidelity Advisor Value Leaders A
MTRRX19.23N/A
N/A
MFS Total Return R2
NWJEX105.69N/A
N/A
Nationwide NYSE Arca Tech 100 Idx R6
WOFRX59.47N/A
N/A
Allspring Opportunity R6
DIVHX27.34N/A
N/A
Cutler Equity Fund

ABSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABSI has been loosely correlated with RXRX. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ABSI jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABSI
1D Price
Change %
ABSI100%
+1.83%
RXRX - ABSI
60%
Loosely correlated
+0.46%
CRSP - ABSI
59%
Loosely correlated
+2.95%
ABCL - ABSI
59%
Loosely correlated
+7.94%
BEAM - ABSI
57%
Loosely correlated
+4.26%
IMNM - ABSI
51%
Loosely correlated
+2.21%
More